21 Invest, a European investment group, completed the acquisition of Omega Pharma, an Italian player in the R&D and commercialization of food supplements, medical devices and cosmetics. Financial terms were not disclosed. “Building new industrial champions is our main challenge. We found Omega Pharma to be an outstanding entrepreneurial business, focused on technological research and development with high professional standards. We will develop together an ambitious build-up project in the sustainable food supplements sector, as a key starting point for long-term growth," Alessandro Benetton, 21 Invest Chariman and Founder.